1. Home
  2. VAL vs LGND Comparison

VAL vs LGND Comparison

Compare VAL & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valaris Limited

VAL

Valaris Limited

HOLD

Current Price

$58.69

Market Cap

3.9B

Sector

Energy

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$195.30

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VAL
LGND
Founded
1975
1987
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
VAL
LGND
Price
$58.69
$195.30
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$54.80
$243.50
AVG Volume (30 Days)
1.0M
236.1K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.76
EPS
5.61
2.49
Revenue
$2,416,000,000.00
$251,233,000.00
Revenue This Year
N/A
$47.71
Revenue Next Year
N/A
$9.77
P/E Ratio
$10.14
$76.38
Revenue Growth
6.81
64.83
52 Week Low
$27.15
$93.58
52 Week High
$61.70
$212.49

Technical Indicators

Market Signals
Indicator
VAL
LGND
Relative Strength Index (RSI) 66.24 48.63
Support Level $55.95 $188.13
Resistance Level $59.54 $207.06
Average True Range (ATR) 2.03 8.48
MACD 0.61 -0.60
Stochastic Oscillator 80.00 55.25

Price Performance

Historical Comparison
VAL
LGND

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: